Treatment outcome of tuberculosis patients at Ekiti State University Teaching Hospital, Nigeria

Authors

  • Adekunle Adeoti Ekiti State University, Ado-Ekiti
  • Joseph Fadare
  • Tobiloba Elebiyo
  • Ayodele Seluwa

Keywords:

Tuberculosis, HIV/AIDS, Outcome, Treatment, TB/HIV

Abstract

Background: Tuberculosis (TB) is a major public health challenge in developing countries. Clinical audit of treatment outcome is a major indicator of the performance of the TB control programme.

Objectives: The aim of this study was to evaluate tuberculosis treatment outcomes and associated factors among patients attending the directly observed tuberculosis short-course (DOTS) facility in a tertiary healthcare center in Nigeria.

Methods: An eight-year retrospective study of registered TB patients from October 2008 to November 2016. The treatment outcome of patients was categorized using the National TB Control programme guideline.

Results: A total of 592 complete patients’ records was reviewed. There was a slight male preponderance (322, 54.4%) and the majority of the patients were newly diagnosed of tuberculosis (537, 90.7%) especially pulmonary tuberculosis (520, 87.8%). The mean age of registered patients was 38 ± 0.6 years. More than half of the patients (339, 57.2%) had smear-positive pulmonary TB (PTB), (181, 30.6%) smear-negative PTB, while (72, 12.2%) had extra-pulmonary TB (EPTB). Four hundred and three patients (91.6%) had successful treatment outcomes (cured and treatment completed), and the predictors of TB treatment outcome were EPTB (OR 11.4 CI 2.30-57.5 p-value=0.003) and TB/HIV co-infection (OR 0.08 CI 0.025-0.24 p<0.05). TB/HIV co-infection accounted for 13% of patients and this was found to be associated with female gender (OR 2.5 CI 1.48-4.22, p-value≤0.0001) and EPTB (OR 0.2 CI 0.27-12.90, p-value=0.032).

Conclusion: Satisfactory treatment outcome when compared to the global target. However, proper integration of TB/HIV programme would further improve the outcome.

References

References
1. Thumamo, B.P., Asuquo, A.E., Abia-Bassey, L., Lawson, L., Hill, V., and Zozio, T., Molecular epidemiology and genetic diversity of mycobacterium tuberculosis complex in Cross River State, Nigeria. Infect Genet Evol, 2012. 12: p. 671-677.
2. Kooffreh, M.E., Offor, J.B., Ekerette, E.E., and Udom, U.I., Prevalence of tuberculosis in Calabar, Nigeria: A case study of patients attending the outpatients Department of Dr. Lawrence Henshaw Memorial Hospital, Calabar. Saudi J Health Sci, 2016. 5: p. 130-133.
3. Ehlers, V.J. and Aragaw, G.S., An audit of diagnosis and treatment of tuberculosis in Ethiopia. Afr J Prm Health Care Fam Med, 2014. 6(1): p. 1-6.
4. Tola, A., Minshore, K.M., Ayele, Y., and Mekuria, A.N., Tuberculosis Treatment Outcomes and Associated Factors among TB Patients Attending Public Hospitals in Harar Town, Eastern Ethiopia: A Five-Year Retrospective Study. Tuberc Res Treat, 2019. 2019: p. 1503219.
5. W.H.O, Global Tuberculosis Control: WHO report 2016. 2016, World Health Organisation: Geneva:Switzerland.
6. World Health Organization, Global Tuberculosis Report 2017, in Tuberculosis. 2017, World Health Organisation: Geneva.
7. Berhe, G., Enquselassie, F., and Aseffa, A., Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray region, northern Ethiopia. BMC Public Health (2017) 17:236, 2012. 12(1): p. 537.
8. FMoH, National Tuberculosis and Leprosy Control Program (NTBLCP) Workers Manual Final Draft. 2008, Federal Ministry of Health Nigeria.
9. Sariem, C.N., Ndukwe, H.C., and Dayom, W.D., Assessing the effectiveness of Directly Observed Therapy short-course (DOTs) for tuberculosis in a Nigerian hospital. Journal of Pharmacy and Bioresources, 2012. 9(2): p. 116-121
10. Ukwaja, K., Alobu, I., Ifebunandu, N., Osakwe, C., and Igwenyi, C., From DOTS to the Stop TB Strategy: DOTS coverage and trend of tuberculosis notification in Ebonyi, southeastern Nigeria, 1998 - 2009. Pan African Medical Journal, 2011. 9(12): p. 1-9.
11. Lienhardt, C. and Ogden, J.A., Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm? Trop Med Int Health, 2004. 9(7): p. 833-841.
12. Umar, A., Nigeria: Why Tuberculosis is On the Increase, Dr Mansur Kabir, Editor. 2008.
13. W.H.O, Global Tuberculosis Control: Surveillance, Planning & Financing; 2008. 2008, World health Organisation: Geneva.
14. WHO, Global Tuberculosis Report. 2017, World Health Organization: geneva.
15. Itah, A.Y. and Udofia, S.M., Epidemiology and endemicity of pulmonary tuberculosis (PTB) in Southeastern Nigeria. Southeast Asian J Trop Med Public Health, 2005. 36: p. 317‑323.
16. Nwanta, J.A., Umeononigwe, C.N., Abonyi, G.E., and Onunkwo, J.I., Retrospective study of bovine and human tuberculosis in abattoirs and hospitals in Enugu, Nigeria. . J Public Health Epidemiol, 2011. 3: p. 329‑336.
17. Erah, P. and Ojieabu, W.A., Success of the Control of Tuberculosis in Nigeria: A Review. International Journal of Health Research,, 2009. 2(1): p. 3-14.
18. W.H.O, The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. 2006, World Health Organisation: Geneva.
19. Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., and Dias, H.M., WHO's new end TB strategy. Lancet, 2015. 385(9979): p. 1799–1801.
20. Worku, S., Derbie, A., Mekonnen, D., and Biadglegne, F., Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: nine-years retrospective study. Infectious Diseases of Poverty, 2018. 7(16): p. 1-8.
21. Schurz, H., Salie, M., Tromp, G., Hoal, E.G., Kinnear, C.J., and Moller, M., The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics, 2019. 13(1): p. 2.
22. Styblo, K., Overview and epidemiological assessment of the current global tuberculosis situation: with an emphasis on tuberculosis control in developing countries. Bull Int Union. Tuberc Lung Dis 1988. 63: p. 39-44.
23. Lee, J.Y., Diagnosis and treatment of extrapulmonary tuberculosis. . Tuberculosis and respiratory diseases, 2015. 78(2): p. 42-55.
24. Sunnetcioglu, A., Sunnetcioglu, M., and Binici, I., Comparative analysis of pulmonary and extrapulmonary tuberculosis of 411 cases. Ann Clin Microbiol Antimicrob, 2015. 14(34).
25. Tiwaria, B.R., Karkib, S., Ghimirec, P., Sharmad, B., and Mallae, S., Factors associated with high prevalence of pulmonary tuberculosis in HIV-infected people visiting for assessment of eligibility for highly active antiretroviral therapy in Kathmandu, Nepal. WHO South-East Asia Journal of Public Health, 2012. 1(4): p. 404-411.
26. Berg, S., Schelling, E., Hailu, E., Firdessa, R., Gumi, B., and Erenso, G., Investigation of the high rates of extrapulmonary tuberculosis in Ethiopia reveals no single driving factor and minimal evidence for zoonotic transmission of Mycobacterium bovis infection. BMC Infec Dis, 2015. 15(1): p. 112.
27. Mekonnen, D., Derbie, A., and Desalegn, E.T.B., HIV co-infections and associated factors among patients on directly observed treatment short course in northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes, 2015. 8(1): p. 666.
28. Assefa, T., Kirubel, M.M., Yohanes, A., and Abraham, N.M., Tuberculosis treatment outcome and associated factors among eastern Ethiopia: A five year retrospective study. Tuberculosis Research and treatment, 2019.
29. M Endris, F Moges, Y Belyhun, E Woldehana, and Esmael, A., Treatment outcome of tuberculosis patients at Enfraz health center, Northwest Ethiopia : a five year retrospective study. Tuberculosis research and treatment, 2014.
30. WHO, Nigeria: Tuberculosis Profile. 2018, World Health Organisation.
31. Oyefabi, A., Adetiba, E., Leeshak, E., and Adesigbin, O., Tuberculosis and the determinants of treatment outcome in Zaria, North Western Nigeria- A nine-year (2007 -2015) epidermiological review. J med Trop, 2017. 19: p. 116-122.
32. Ukwaja, K., Oshi, S., Alobu, I., and Oshi, D., Profile and determinants of unsuccessful tuberculosis outcome in rural Nigeria: implications for tuberculosis control. World J Methodol, 2016. 6(1): p. 118 -125.
33. Murray and Nadel’s Textbook of Respiratory Medicine. 4 ed, ed. R.J. Mason, et al. 2005, Philadelphia: PA: Elsevier Saunders.
34. Fatiregun, A.A., Ojo, A.S., and Bamgboye, A.E., Treatment outcomes among pulmonary tuberculosis patients at treatment centers in Ibadan, Nigeria. Annals of African Medicine, 2009. 8(2): p. 100-104.

Downloads

Published

2020-09-30